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ABSTRACT Bioassays of products based on Bacillus fliuiingiensis var. isruelensis have been 
carried out according to standard protocols. These analyses revealed that the slopes of the- 
log-probit transformed concentration mortality curves of various pro-ducts were different from 
that of the international standards (IPS82 for B. tliuringiensis isruelensis). For statistical rea- 
sons, this invalidates the tests. Products giving various slopes of the concentration mortality 
burves will obtain different potencies when estimated at a LCgO level *an when estimated at 
PC50 level, as normally done. The LCg0 level is probably more relevant for the field effect. 
/Changing the median particle size of a product in a non destructive way’resdts in change of ‘ 
plope and LC50 and thereby potency. Therefore, potency of a product as measured in these 
(bioassays is not just a measure of the quantity of B. thringiensis isruelensis crystal protein 
present, but a function of product parameters like median particle size. Biochemical methods 
for quantification of toxin can therefore not relate simply to potency of the products obtained 
equal particle size of products and samples to obtain parallel dose response. 
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this method. It is suggested that standard protocols for bioassay may be changed to assure 
Bacillus tlzuringiensis variety isruelensis, bioassay, dosemortahty, particle size 
Bacillus thuringiensis VAR. israelensis is an ento- 
mopatho enic bacterium that produces a protein- 
aceous incrustration in a crystalliferous body (i.e., 
the protein crystal or delta-endotoxin), The protein 
crystal of B. thuringiensis israeleizsis consists of a 
protoxin that is dissolved and then enzymatically 
activated in the midgut of the mosquito larvae 
(Charles and de Barjac 1981). Because of its high 
degree of specificity and no known vertebrate tox- 
icity of commercial strains, B. thuringiensis has 
been used commercially for many years (but see 
Damgaard 1995). In recent years, a better under- 
standin of the mode of action and genetic tech- 
niques %as expanded, and the use and our basic 
knowledge of the bacterium and especially of the 
delta-endotoxins has improved (reviewed by Höfte 
and Whiteley 1989, Knowles et al. 1989). 
Products based on the most commonly used 
strains of B. thuringiensis are given a potency 
based on bioassays on insts. Concentration-mor- 
tality data are obtained, transformed to a log-probit 
scale, and potency is obtained by comparing the 
estimated LCs0 of a test substance with that of a 
standard with a known potency (Dulmage 1973, de 
Barjac 1985). The rationale is that daiIy within-lab- 
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oratory or interlaboratory variations can be ac- 
counted for by using relative estimates. The stan- 
dards” are internationally recognized standards 
(e.g., HD-l-SL1980 for B. thuringiensis kurstaki 
and HD-968-S-1983 and IPS82 for B. thuringien- 
sis israelensis). 
To reduce the interlaboratory variation, proto- 
cols were also suggested to standardize the bioas- 
says (McLaughlin et al 1984, deBarjac 1985). 
These protocols were used when a number of lab- 
oratories set the potency of the current B. thurin- 
giensis israelensis standards, Nevertheless, the val- 
ue setting of the B. thuringiensis israelensis 
standards did reveal interlaboratory variation. The 
reasons for these variances were not analyzed 
(McLaughlin et al. 1984). 
It is a statistical prerequisite for the comparisons 
of LC50 values that the concentration-mortality 
curves are parallel (e.g., that the slope of the con- 
cencentration mortality curves [slope for short be- 
low] are the same). This requirement is of course 
the same whether commercial B. thuringiensis 
products, single toxins, dissolved toxins, or effect 
of extracts from genetically engineered plants are 
comp.ared. When comparing a standard and a test 
sample, the difference in slope of the 2 curves has 
to be large to be statistically different because of 
the rather great variance of bioassays. Accordingly, 
the criteria are often met and manv authors do not 
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Tabashnik et al. (1993) analyzed slope and LCso 
data from 54 bioassays on 15 populations of Plu- 
tella xylostella (L.) and concluded that the varia- 
tion in slope in bioaasays is not biologically mean- 
ingfull. The problem with this and other studies on 
bioassay methods is that the amount of data used 
was too small compared to the variation of the bio- 
assay to see if slope was a product-dependent pa- 
rameter. 
This study contains bioassay data of commercial 
products and test formulations with B. thuringien- 
sis israelensis collected over 4 yr, ~ 1 , 5 0 0  bioassays. 
Average slope of various product types are ana- 
lyzed to see if the average values are different from 
that of the standard, IPS82, and if they are product 
or product type dependent. The slope of the prod- 
ucts are related to particle size of the products and 
the particle size is changed experimentally to show 
the effect on the slope of the dose mortality curves. 
The consequences of that for the measured poten- 
cy are demonstrated. 
The results are discussed in relation to the thor- 
ough investigations carried out by the Working 
Group on Biological Control of Vectors in WHO, 
which tried to standardize test methods and deter- 
mine potency of various proposed international 
standards (WHO reports and personal communi- 
cations 1979-1981 from the Working Group in 
whch ORSTOM participated). 
Materials and Methods 
Mosquito Assays. The A. aegqpti strain ob- 
tained from K. Arevad (The Danish Pest Infesta- 
tion Laboratory) in 1987 were used for the bioas- 
says in Copenhagen. The strain originated from 
The London School of Hygiene and Tropical Dis- 
eases. 
. Larvae were fed with a mixture of ground dog 
biscuits and fish flakes used to feed fish in aquaria. 
Larvae were reared at 27°C and a photoperiod of 
12:12 (L:D) h, and early 4th instars were used for 
the testing, except when specified. Results of the 
bioassays were read after 24 h. The protocol was 
identical to McLaughlin et al. 1984, although 
waxed cups were replaced by 150-ml plastic cups. 
Bottled water was used for rearing and testing be- 
cause it was free of chlorine and its quahty was 
constant. 
We tested wettable powders of Bactimos WP 
(Novo Nordisk, Bagsvaerd; Denmark), and primary 
powders Vectobac TP (Abbot, Chicago, IL), Pri- 
may Powders (Novo Nordisk), and the intema- 
tional standard IPS82 (Institut Pasteur, Paris). The 
flowable products tested were Acrobe (Becker Mi- 
crobials Products, FL), Skeetal FC (Novo Nor- 
disk), Teknar HPD (Sandoz, Zürich), Vectobac 
12AS and Vectobac FC (Abbot) and a number of 
technical products from Novo .Nordisk: "-1, 
Sludge-1, Sludge-&. The sludges were unformulat- 
ed, concentrated beers, and "-1 was an internal, 
fluid standard also used for biochemical potency 
control. 
Powder samples were allowed to stand in water 
for 30 min and a droplet of a wetting agent was 
added if the sample was not allready formulated. 
The sample was then homogenized (IKAmag 
for 30 s and further diluted to produce a series of 
test dilutions. Flowable products were homoge- 
nized in water (Warren blender) for 30 s and then 
diluted further to produce the serial dilutions. 
These homogenization steps did not disintegrate 
particle size of the tested products. From these 
dilutions, 10-g samples were transferred into 
150-ml cups with 90-g of water and 20 mosquito 
larvae. 
To examine the feeding activity of the larvae sur- 
viving test concentrations, they were carefully sam- 
pled with a pipette and transferred to another cup 
with water. Finely ground charcoal powder was 
added and the larvae were picked up after 30 min 
and squeezed between 2 glass plates for the mi- 
croscopical examination of the gut content. 
Concentration-mortality data were log-probit 
transformed, analyzed by linear regression and the 
slope of the (transformed) dose mortality data was 
calculated. A 1-sided analysis of variance verified 
that the data actually fit a straight line. Nonvalid 
tests were discarded. 
For potency calculations, we used the intema- 
tionally recognized standard for mosquito assay, 
IPS82 (15,000 ITU/mg) provided by Institute En- 
tomopathogene, Institut Pasteur, Paris, France. 
Standard vials are kept at -18°C in our laboratory. 
EOA5 Homogenizer with Polytron PTA 205 shaft) \ 
@ 
Product potency was calculated by: 
where (A) is the product and (STD) is the stan- 
dard. 
Each sample was bioassayed at least 3 times on 
various days and the results presented are average 
values: log transformed for LC50 and potency val- 
ues, arithmetric means for slope. 
Physical Analysis. Particle size was measured 
by laser diffractometry on a Sympatec Helos par- 
ticle size analyzer in Novo-Nordisk, Bagsvaerd, or 
in Entotech, Novo-Nordisk, Davis, California. One 
of 2 lenses were used for final particle size analysis: 
one covering from 1 to 1,000 pm or one covering 
from 0.1 to 100 pm. In this way we obtained a 
bution. For each product, at least 2 samples were 
weighed and suspended in water, and for each, 
sample at least a double determination of particle 
size was made. The printouts of the 2 machines 
were slightly different, one giving a grid scale, the 
other not. Both machines made autoniatic scale 
corrections. For the y-axis this implied that curves 
with a high number in the scale are more narrow 
that those ;wi+ a, loyl number . -  of the; scale. 
r 
Y 
(, 
best match between lens and particle size distri- 
! 
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Table 1. Slope of the log-probit transformed dose mortality data from 3 yr 
Product& 1990 slope" n 1991 slope n 1992 slope n 1993 slope 
IPS 8zb - O 3.85 C 1.01 33 3.87 C 0.73 71 3.81 2 0.51 
4.17 C 0.87 50 4.22 C 0.55 
3.42 2 0.98 141 3.43 10.84 
FlowablesC 4.12 *. 0.75 32 4.33 C 0.77 
P nw der s 3.20 C 0.58 37 - 
"I Analysis of all data (SAS Institute 1989) showed a significant difference between the mean values of the slopes ( P  < 0.01). There 
was no significant difference within the years for the product groups ( P  > O J O ) ,  but none of the groups had the same slopes (P '<  
0.01). 
0 An internal powder standard was used in 1990 and represents all powder data from that year. 
=The flowable data represents products and fermentations that have not been stored above 5°C. 
3/ IPS82 is the intemational standard for B.  tlturingiensis israelensis. 
Particle size was manipulated by sonicating pow- 
der products or freezing fluid samples. The powder 
was'dispersed in water in a plastic beaker, agitated, 
and allowed to stand for 30 min. The beaker was 
then put in an ice bath and the sample sonicated 
at low intensity. In a preliminary test, a primary 
powder was sonicated in O, 30, 60, 90, 120, 240, 
and 480 s. From this experiment of sonication 
times, O, 120, and 480 s were selected, giving 3 
different particle size ranges. Nine bioassays were 
carried out with 2nd and with 4th instars on the 
sonicated powders of the type used in the prelim- 
inary test. Three tests were carried out with anoth- 
er type of primary powder. 
The fluid products were stored in a freezer at 
-18°C overnight to allow for formation of crystallic 
ice in the samples. Fast freezing in liquid nitrogen 
and freezing of a product with a high content of 
glykol did not result in a change of particle size 
and are not used for further analysis here. Samples 
analyzed for particle size distribution were also 
bioassayed and slope and potency determined. 
Frozen samples were rethawed and homogenized 
for 30 s before analysis. 
Results 
The slope of the concentration-mortality curves 
in tests with IPS82 averaged 3.86, based on data 
from 1990-1993 (Table 1). Corresponding figures 
for flowable products based on concentrated 
sludge and for powder products (spray dried) 
were-with a few exceptions-in the range of the 
mean values of 4.21 and 3.31, respectively. These 
values were significant different (P<O.O1). 
Most of the fluid products had a narrow particle 
size distribution with a median particle size =lo 
pm. The exception was Acrobe with a large parti- 
cle range (Table 2; and Fig. 1 [note y-scales, the 
peak of Acrobe is actually 3 times lower than the 
peak of Skeetal].). By contrast, the powders had a 
higher particle size and larger variation (Table 3; 
Fig. 1). The exception was Vectobac TP which had 
a small particle size similar to that of the flowables, 
but a larger particle size range. 
In general, fluid samples produced higher slopes 
in bioassays than powder samples. However, 2 ex- 
ceptions were informative: Acrobe had a low slope 
and Teknar TP had a high slope. For all samples, 
there was a negative correlation between slope and 
median particle size (Fig. 2). 
Before sonication, the tested primary powders 
had a median particle size close to 40 pm. The 
preliminary test of a primary powder showed that 
it broke up in 2 fractions with smaller, 1-2 pm, 
and larger, 3040  pm particles. Extendmg sonica- 
tion time resulted in a higher frequency of small 
particles and a significant lower frequency of the 
large particles; at 480 s, almost no large particles 
revained (Fig. 3). Experiments were continued 
using sonication times of O, 120, and 480 s, which 
gave almost the same pattern of particle size dis- 
tribution each time except when applied to anoth- 
er type of primary powder. This powder proved to 
be much more susceptible to sonication. After 
120-s sonication, median particle size was 3 ,um 
Table 2. Median volume of particle size of commercial and laboratory products 
Slope 1 SE 
Skeetal 12 1 peak 4.37 C 0.93 
Teknar HPD 9 and 50 2 peaks 3.60 C 0.97 
;' I Vectobac 12AS 11 1 peak 3.64 C 0.41 
5 broad range 3.80 C 0.96 .i' Acrobe 
Unformulated 7-8 1 peak 4.40 C 0.85 
4.84 C 0.51 Fluid Standard 3.8 1 peak 
Primary Powder 3841  1 peak 3.63 C 1.0 
IPS 82 1.5 and 15 2 peaks 3.87 +. 0.73 
IPS82, light sonicated 1.5 and 15 2 peaks 3.91 
IPS82, intense sonicated 0.5-1.5 2 peaks 5.1 
Distribution 
of particles Sample Median vol, pm 
When the product had particles distributed in two size classes, the median of each class is indicated. When various products of the 
same type were tested, the range of peak values are given. 
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Fig. 1. Particle size distribution of some of the tested B. flcringiensis isruelensis powders after light (0.3 W) 
homogenization in water; (A) Vectobac TP R, (B) Bactimos WP, (C) Vectobac FC, (D) Acrobe FC, (E) Teknar FC, 
and (F) a concentrated sludge. 
and there were no big particles. After 480 s, me- 
dian particle size was 2 pm. 
For the 2nd and for the 41th instars, potency 
decreased and slope increased with sonication time 
(Table 4; Fig. 3). Bioassays with the 2nd type of 
powder showed that LCs0 increased so much that 
a partial destruction of the B. thuringiensis israe- 
lensis crystal was suspected (Table 4). 
Sonication was also applied to the standard, 
IPS82. Without sonication, IPS82 consisted of 2 
fractions of particles; small particles with a mean 
size of 1.5 pm and larger particles of -15 pm. A 
light sonication (2  W for 30 s) reduced particle size 
only sligthly and had no influence on the bioassay. 
More intense sonication (20 W for 30 s) reduced 
the number of larger particles and increased the 
3 
Table 3. Average LCso, slope, and potency of products tested in bioassays 
f 
Product LC50 2 SE Slope t SE n Potency t SE * 
Skeetd FC 0.123 f 0.038 4.12 t 0.86 41 830 t 200 
Teknar HPD 0.0911 t 0.0271 3.67 f 0.81 
Vectobac TP 1993 0.0108 4.78 3 8,200 % 1,800 
Vectobac 12.4s 0.107 f 0.018 3.64 f 0.41 4 950 f 180 
390 t 110 Acrobe 0.327 f 0.165 3.50 t 0.70 5 
40 3,600 f 950 Bactimos WP 0.0256 i 0.0055 3.64 f 1.02 
IPS 82 0.00672 f 0.00160 3.82 f 0.83 115 15,000 
15 1,2001 200 
n, number of bioassays. 
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Fig. 2. Correlation between median particle size of a 
product and slope of the dose mortality curve when the 
product is bioassayed. All products and particle size ma- 
nipulated products based on 3 or more bioassays are in- 
cluded in the table. 
number of smaller particles (Fig. 4), but it did not 
change the slope though the LC50 nearly doubled. 
The sonication, particularly at high intensity, 
could have resulted in a partial destruction of the 
toxin (e.g., by splitting the crystal into subunits). 
Therefore, we evaluated a nondestructive method 
to change particle size. Slow freezing of a protein 
solution is known to result in flocculation causing 
larger particles. 
Five formulated (Skeetal and Vectobac) and 5 
unformulated samples were frozen (-18"C), LCso 
and slopes were measured before and after freez- 
ing. Freezing resulted in decreased slope LCS0s. 
The effect was smaller for the formulated products 
than for the unformulated (Table 5) .  
To confirm that this effect in the bioassay was 
caused by induced changes in the products, a 
sludge was split in 2 and 1 of these formulated. 
The formulated and the nonformulated were fur- 
ther split in 2 and l of each was frozen (-lS°C), 
the other was not. In this way, we obtained a fro- 
zen, formulated sludge, a nonfrozen, formulated 
sludge, a nonformulated, frozen sludge and a non- 
formulated, nonfrozen sludge, all of the same ori- 
gin. The 4 samples were tested in bioassay and for 
particle size, except for the formulated sample 
where the tests on the frozen sample mistakenly 
was not tested. Freezing increased particle size, 
and decreased slope and potency. The effect was 
most pronounced for the unformulated sludge (Ta- 
ble 6). 
After a bioassay of the standard, surviving mos- 
quito larvae were transferred to clean water and 
allowed to ingest charcoal powder particles for 30 
min. At all concentrations, a few larvae did not 
ingest anythmg and died, but most of the larvae 
fed vigorously and filled the oesophagus with char- 
coal powder particles within 30 min. There was no 
correlation between the amount of charcoal pow- 
der particles taken in and the previous test con- 
centration (data not shown). Larvae from medium 
test concentrations often had filled their gut with 
macerated pieces of their dead cup-fellows. 
Discussion 
Calculations for a large number of bioassays in 
this study showed that the concentration-mortality 
curves were often not parallel, but the slopes of 
the curves were dependent on the product type. 
In general, fluid products have steeper slopes than 
powder products (Tables 2 and 3) with 2 infor- 
mative exceptions: a flowable with a wide particle 
size distribution gave a low slope and a powder 
with a small median particle size gave a high slope. 
Therefore, the slopes are probably a function of 
particle size/distribution and not of product type. 
In principle, products giving different slopes in 
dose effect studies cannot be compared (Finney 
1971), which put into question the value of bio- 
assay following the standard bioassay rocedures. 
Change of particle size also changecfLCS0 of the 
products. Decreasing particle size increased LCso 
(and thus decreased the calculated potency) and 
increasing particle size decreased LCs0, thus in- 
creasing the calculated potency. Sonication may re- 
sult in damage of the toxin crystals and thus may 
cause the decrease in potency, but it is difficult to 
see how freezing could increase the amount of tox- 
in. Therefore, the changes in LCsOs in these trials 
are not regarded to reflect changes in amount of 
toxin, but to be a function of particle size/distri- 
bution. 
This relation was confirmed by changing the 
particle size of various samples. By sonication of 
primary powders, particle size was reduced and the 
slope increased (Table 4). Altematively, by slow 
freezing fluid samples, particle size increased and 
slope decreased (Tables 5 and 6). Our results are 
in agreement with those of Guillet and Quval 
(1985), who found that intense sample homogeni- 
zation increased the LCso of various products and 
the standard IPS82 to mosquito larvae. Guillet and 
Duval (1985) speculated that the result was an ef- 
fect of particle size, but this parameter was not 
measured. 
The LCSO in a bioassay is a function of concen- 
tration and availability of the toxin and the change 
in particle size must influence the latter parameter 
since the amount of toxin present was not changed 
in the trials. By changing particle size, we changed 
the availability of the toxin to the mosquito larvae. 
A simple explanation for the influence of particle 
size on LC50 would be a preferential uptake of 
some sizes, but Dahl et al. (1993) did not find that 
particle size in the range of 0.6-5.8 pm had a ma- 
jor influence on the chance of ingestion. This is in 
the lower range of the particle sizes examined 
here, but Dahl (1988) has also shown that particles 
up to 100 pm are ingested. 
Sublethal feeding inhibition may also explain the 
influence of particle size: lepidopteran larvae eat- 
ing (e.g., B. thuringiensis kurstaki with their arti- 
ficial diet) but not dying within the time of the 
experiment are stunted and eat less, which is easily 
observed in the laboratory. A similar sublethal eat- 
366 JOURNAL OF ECONOMIC ENTOMOLOGY Vol. 90, no. 2 
A VOLUME DISTRIBUTION 
PARTICLE DIAMETER (phi;) 
B 
o. 1 1 10 100 
PARTICLE DIAMETER (pM) 
C 
o. 1 1 10 1 O0 
PARTICLE DIAMETER (pM) 
D VOLUME DISTRIBUTION 
PARTICLE DIAMETER OlM) 
E 
5.0 
2.5 
;::1 : : . :::::: 
:;:i i ; i i i 
:r:: : : T : : : : i :  ,:::. : : : :::::i 0.0 
o. 1 1 10 1 O0 
PARTICLE DIAMETER (pM) 
F 
PARTICLE DIAMETER (pM) 
Fig. 3. Particle volume size distribution of a B.  thuringiensis isruelensis primary powder (A-C) and of the standard 
IPS (D-F) after increasing levels of sonication from top to down. Note the change in scale between (A) and (B)- 
(C) .  (A) B.  thuringiensis isruelensis primary powder without sonication, (B)sonicated for 120 s in water and (C) 
sonicated 480 s. Without sonication, the primary powder has a peak at 45 pm and a median of 37 pm. (B) Sonication 
splits up the larger particles and creates 2 groups of particles of reduced size and with a total median of 9 pm. 
Further sonication (C) increases the volume of small particles and further reduces the volume of larger particles, 
median 3.6 pm. Median values are used in the calculations showed in Table 4. (D) Without sonication, IPS82 consisted 
of larger and smaller particles. Intense sonication was necessary to split up IPS82 particles (E-F) and thus influence 
the bioassay, but the intense sonication may also have split up B. thuringiensis isruelensis crystals in its subfractions, 
thus influencing the bioassay in an unpredictable way. 
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Table 4. Two powder products sonicated to reduce mean particle size and estimated potency 
Distribution 
of particles Test larvae  tison son Median vol, pm Potency F SE Slope 2 SE 
2nd Instar O 37 1 peak 16,600 2 3,000 2.45 2 0.77 
1st Powder 120 9.0 2 peaks 10,400 F 900 1 3.20k 0.98 
480 3.6 2 peaks 10,800 -I- 2,200 3.15 ir 0.97 
4th Instar O 37 
Ist Powder 120 9.0 
480 3.6 
1 peak 15,100 2 1,300 2.90 5 0.49 
2.84 2 0.42 2 peaks 12,700 5 1,900 
3.15 F 0.32 2 peaks 10,000 5 1,200 
4th Instar O 39 ir 1 1 peak 11,800 ir 800 3.21 zk 0.21 
2nd Powder 120 2.7 F 0.4 1 peak 6,700 F 1,000 3.97 2 0.40 
480 2.0 F 0.2 1 peak 5,200 F 1,000 4.55 -+ 0.92 
Powders of different origin were used for the tests. The 2nd instar showed to be less resistant to sonication. 
ing inhibition may take place for the mosquito lar- 
vae. At larger particle sizes, this may prevent mos- 
quito larvae from taking in a lethal dose, provided 
the dose per particle was big enough to stop the 
feeding but not big enough to kill them. Sublethal 
effect would thus be a function of particle size and 
could explain the dependency of slope and LC50 
on the particle size. To test this hyphotesis, fine 
grounded charcoal powder was added to the test 
beakers after 24 h after reading the assay, and in- 
gestion by the larvae followed. This analysis 
showed that at all concentrations, nearly all living 
mosquito larvae ingested particles and therefore 
could also ingest the B. thuringiensis isruelensis. 
Also, many larvae had there stomach full of mac- 
erated pieces of their dead fellows, showing that 
they had been taking in food for a longer period. 
Obviously, the surviving larvae had not stopped 
feeding during the assay and there was no suble- 
thal effect in this aspect. 
The slope of the dose mortality curve is a func- 
tion of the heterogenity of the product effect. If 
product availability is a function of particles sizes, 
products with broad ranges of particle size distri- 
bution will also have low slopes. This is demon- 
' strated by the analysis of Acrobe, a fluid product 
with a low median particle size, but a broad range 
of particle size distribution and a low slope. In gen- 
eral, a product with small particles is more hom- 
ogenously distributed in the water than a product 
with larger particles and small particles sink slower 
than bigger, being suspended for a longer time. 
This could explain the generally higher slopes of 
the product consisting of mostly small particles 
compared to those with the larger particles. 
Table 5. Effect of freezing on LC50 and slope 
Sample LCSO index Slope index 
Sludge 100 100 
Formulated 100 100 
Frozen sludge 77 & 13 87 t 26 
Formulated and frozen 83" 8 912 6 
Five formulated and 5 unformulated samples were frozen. 
The tested products are of different origin and potency. There- 
fore, indexes are used toïndicate direction of change. 
Though simple, this theory has a problem: A. ae- 
gypti larvae also brush the bottoms of the contain- 
er for particles (Widahl 1988) and should thus in- 
gest the large particles. 
Implications for the Value of Bioassays. The 
investigation shows that particle size influences tlie 
toxicity of a product as tested in a bioassay on 2nd- 
and 4th-instar larvae of A. aegypti. The smaller the 
median particle size, the steeper the slope of the 
concentration-mortality curve. This correlation of 
particle size, slope and potency may also explain 
within- and interlaboratory variations as observed 
in the studies carried out by the WHO Working 
Group on biological control when they tried to set 
standards for protocols and potency values of stan- 
dards. Ddmage's (1980) report to the Working 
Group stated that the slope of the standard IPS78 
was lower than that of the tested fermented beers. 
Dulmage anticipated that this might have resulted 
from differences in strain origin of the B. thurin- 
giensis ist-aelensis strains used. In the same report, 
Dulmage tested spray-dried powders from some of 
these fermentations and obtained a slope similar 
to that of the standard and significantly lower than 
of the fermented beers tested on the same days. 
Because spray-drymg increases particle size, our 
results are in agreement with those of Ddmage 
(1980). 
The potency of IPS80 and of IPS82 was set rel- 
ative to the older standard IPS78, which by defi- 
nition was given the potency 1,000 ITU/mg. But 
analysis of the results from one of the collaborating 
laboratories showed (Hougard and Coz 1982) that 
at least IPS80 had a slope significantly higher than 
that of IPS78 (3.47k.32 versus 2.63k.24). IPS80 
was produced in small amounts and quickly used 
up. Therefore, IPS82 was produced in the same 
way and from the same strain. They may therefore 
be assumed to be equal and the slopes of the dose 
mortality curves are the same (de Barjac and Lar- 
get-Thiery 1984). Because the slope of the orginal 
standard (IPS78) and of the later standards are dif- 
ferent, in reality the potency of the 82 standard is 
obscure, A similar problem does noi seem to be 
related with the USDA B. thuringiensis isruelensis 
standard HD-968-$1983. According to Dulmage 
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Table 6. Influence of formulation and freezing on particle sire distribution, slope, and estimated potency 
Sample . Median vol, pm Slope Potency 
Sludge 8 4.22 2 0.83 1,560 f 280 
Frozen sludge 40-65 2.08 ir 0.60 2,850 f 30 
Formulated sludge 12 3.84 f 0.63 1,250 2 170 
Formulated and frozen sludge 94 ND ND 
Particle size distribution shown in Fig. 1F. ND, not determined 
et al. (1985), the slopes of concentration-mortality 
curves for IPS78 and for this standard were the 
same. 
The implication of our results is that bioassays 
done with products of different particle sizes com- 
pared to that of the standard do not accurately re- 
flect the concentration of B. thuringiensis israelen- 
sis toxin among products, but .does provide 
valuable information about formulation effect. Po- 
tency is not a simple function of the crystal protein 
concentration but also to a large extent is a func- 
tion of availability of the toxin. Therefore, although 
nonbioassay methods may be only roughly corre- 
lated to potency as measured in bioassays, they 
may provide better estimates of the concentration 
of crystal protein (e.g., Skovmand and Sterndorf 
1994). To ensure that the bioassays reflect B. thu- 
ringiensis israelensis activity, independent of for- 
mulation differencies, all products and the stan- 
dard must be homogenized to the same small 
particle size (i.e., similar to single cells). This ap- 
proach was suggested by the the Working Group 
(WHO Report 1981), but was not followed in the 
final protocols (de Barjac 1985, McLaughlin 1984). 
Analyses of the results of the bioassays carried out 
by the involved laboratories during the work of the 
Worldng Group also showed that this suggestion 
was never followed. The dilemma is of course that 
the product may then no longer reflect the abilities 
in the field-if these assays ever did so. 
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